4 free views remaining today

hyperlipoproteinemia type IV

ICD-10 Codes

Related ICD-10:

Description

Hyperlipoproteinemia Type IV: A Comprehensive Overview

Hyperlipoproteinemia Type IV, also known as simple hypertriglyceridemia, is a condition characterized by an isolated elevation of Very Low-Density Lipoproteins (VLDL) in the blood. This leads to persistently high levels of plasma triglycerides, while plasma cholesterol and phospholipids are usually within normal limits.

Key Features:

  • Elevated VLDL levels
  • Persistently high plasma triglycerides
  • Normal or slightly elevated plasma cholesterol and phospholipids
  • Precocious atherosclerosis (early development of atherosclerosis)
  • Abnormal glucose tolerance
  • Atheroeruptive xanthoma (a type of skin lesion)

Causes:

  • Polygenic inheritance pattern, meaning it is influenced by multiple genes
  • Often secondary to another disorder, such as hypothyroidism, diabetes, or pancreatitis

Symptoms:

  • Mild chronic or migratory oligoarthritis (joint pain and inflammation)
  • Fever and elevated white blood cell count may occur in some cases

Treatment:

  • Treatment depends on the underlying cause of the condition
  • Management of associated disorders, such as hypothyroidism or diabetes, is crucial

References:

  • [1] Type IV hyperlipoproteinemia is characterized by fasting subjects with elevated plasma triglycerides that are transported by very-low density lipoproteins (VLDL) ([9])
  • Elevated VLDL levels and persistently high plasma triglycerides are hallmarks of this condition ([6], [8])
  • Precocious atherosclerosis, abnormal glucose tolerance, and atheroeruptive xanthoma may occur in individuals with Type IV hyperlipoproteinemia ([3], [4])

Additional Characteristics

  • Elevated Very Low-Density Lipoproteins (VLDL) levels
  • Persistently high plasma triglycerides
  • Normal or slightly elevated plasma cholesterol and phospholipids
  • Precocious atherosclerosis
  • Abnormal glucose tolerance
  • Atheroeruptive xanthoma
  • Mild chronic or migratory oligoarthritis
  • Polygenic inheritance pattern
  • Associated with hypothyroidism, diabetes, or pancreatitis

Signs and Symptoms

Hyperlipoproteinemia Type IV Signs and Symptoms

Hyperlipoproteinemia Type IV, also known as familial hypertriglyceridemia, is a genetic disorder characterized by high levels of triglycerides in the blood. The condition can cause various signs and symptoms, which may vary from person to person.

  • Increased plasma VLDL and triglycerides: Patients with type IV hyperlipoproteinemia have increased plasma VLDL (very-low-density lipoprotein) and persistently high plasma triglycerides [6].
  • No noticeable symptoms in some cases: Many people with this condition do not experience any symptoms, but they can realize it when they develop a heart condition or other related health issues [11].
  • Hypertriglyceridemic waist: Some individuals may have an elevated waist circumference (>90 cm in men or >85 cm in women), which is known as hypertriglyceridemic waist [12].
  • Systemic signs and symptoms: Patients with type IV hyperlipoproteinemia may experience systemic signs and symptoms, such as worsening of breathlessness and signs of heart failure [14].

It's essential to note that the symptoms of coronary artery disease can also be present in individuals with type IV hyperlipoproteinemia. These include chest pain with exertion, jaw pain, shortness of breath, severe chest pain, flushing, nausea, and difficulty breathing [5].

References:

[6] Increased plasma VLDL and triglycerides are characteristic of type IV hyperlipoproteinemia. [11] Many people with this condition do not experience any symptoms. [12] Hypertriglyceridemic waist is an elevated waist circumference (>90 cm in men or >85 cm in women). [14] Patients with type IV hyperlipoproteinemia may experience systemic signs and symptoms, such as worsening of breathlessness and signs of heart failure.

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Hyperlipoproteinemia Type IV

Hyperlipoproteinemia type IV, also known as carbohydrate-inducible hyperlipemia, is a condition characterized by high levels of very low-density lipoprotein (VLDL) cholesterol and triglycerides in the blood. To diagnose this condition, several diagnostic tests can be performed.

  • Blood Tests: Blood tests are used to measure the levels of VLDL cholesterol and triglycerides in the blood. These tests can help confirm the diagnosis of hyperlipoproteinemia type IV.
  • Urine Tests: Urine tests may also be performed to rule out other conditions that could be causing the symptoms.
  • Physical Examination: A physical examination can help identify any specific physical findings associated with the different phenotypes of hyperlipoproteinemia, such as xanthomas (fatty deposits under the skin).
  • Family History: A family history of lipid disorders or other risk factors may also be taken into account when diagnosing hyperlipoproteinemia type IV.

According to [1], doctors can diagnose the type and rule out other conditions using blood and urine tests. This informs treatment, which usually involves taking statins and making healthy lifestyle changes.

In addition, laboratory measurement of lipoproteins in the blood is used to confirm the diagnosis of hyperlipoproteinemia [5]. The disorder may only truly be characterized by assessing the composition of plasma lipoproteins in the blood.

References: [1] - Context 4 [2] - Context 9 [3] - Context 5

Additional Diagnostic Tests

  • Blood Tests
  • Urine Tests
  • Physical Examination
  • Family History

Treatment

Treatment Options for Hyperlipoproteinemia Type IV

Hyperlipoproteinemia Type IV, also known as primary endogenous hypertriglyceridemia, is a genetic disorder characterized by elevated levels of triglycerides and very low-density lipoproteins (VLDL) in the blood. The treatment for this condition typically involves lifestyle modifications and medication.

Medications Used to Treat Hyperlipoproteinemia Type IV

Several medications have been approved by the FDA for the treatment of hyperlipoproteinemia Type IV, including:

  • Fenofibrate: This medication has been shown to be effective in lowering triglyceride levels and improving lipid profiles [6][12].
  • Atorvastatin: As a statin, atorvastatin can help lower cholesterol levels and improve overall cardiovascular health [13].
  • Metformin: While primarily used to treat type 2 diabetes, metformin has also been found to be effective in lowering triglyceride levels and improving insulin sensitivity [13].
  • Chenodeoxycholic acid: This bile acid can help lower cholesterol production in the liver and its absorption in the small intestine, making it a useful treatment option for hyperlipoproteinemia Type IV [13].

Other Treatment Options

In addition to these medications, other treatment options may include:

  • Dietary changes: Making healthy dietary choices, such as reducing intake of saturated fats and sugars, can help manage triglyceride levels.
  • Exercise: Regular physical activity can also help improve lipid profiles and overall cardiovascular health.

Monitoring and Follow-up

It's essential to work closely with a healthcare provider to monitor the effectiveness of treatment and make any necessary adjustments. Regular liver function tests should be performed to ensure that medications are not causing any adverse effects [15].

References:

[6] - Fenofibrate has been shown to be effective in lowering triglyceride levels and improving lipid profiles. [12] - Fenofibrate is an approved medication for the treatment of hyperlipoproteinemia Type IV. [13] - Atorvastatin, metformin, and chenodeoxycholic acid are all medications that have been found to be effective in treating hyperlipoproteinemia Type IV. [15] - Regular liver function tests should be performed when using certain medications for the treatment of hyperlipoproteinemia Type IV.

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Hyperlipoproteinemia Type IV

Hyperlipoproteinemia type IV, also known as familial hypertriglyceridemia (FHTG), is a genetic disorder characterized by elevated levels of triglycerides and very low-density lipoproteins (VLDL) in the blood. To accurately diagnose this condition, it's essential to rule out other possible causes of hyperlipoproteinemia.

Primary Genetic Disorders

Hyperlipoproteinemia type IV can be caused by primary genetic disorders, including:

  • Autosomal dominant inheritance: This is the most common form of FHTG, where a single copy of the mutated gene is enough to cause the condition.
  • Autosomal recessive inheritance: In this rare form of FHTG, an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.

Secondary Complications

Hyperlipoproteinemia type IV can also be caused by secondary complications of underlying medical conditions, such as:

  • Obesity and insulin resistance
  • Metabolic syndrome
  • Diabetes mellitus

Differential Diagnosis

To differentiate hyperlipoproteinemia type IV from other forms of hyperlipoproteinemia, clinicians must consider the following factors:

  • Family history: A strong family history of lipid disorders can suggest a genetic component.
  • Physical examination findings: Certain physical characteristics, such as xanthomas (yellowish patches on the skin), can indicate the presence of hyperlipoproteinemia.
  • Laboratory measurements: Measuring lipoproteins in the blood can confirm the diagnosis.

References

  • [3] Differential Diagnosis. Hyperlipoproteinemia may be caused by primary genetic disorders or as secondary complications of underlying medical conditions.
  • [4] On a regular diet patients with type IV hyperlipoproteinemia demonstrate increased plasma VLDL. Plasma triglycerides are persistently increased.
  • [9] Type IV familial hyperlipidemia is also known as familial hypertriglyceridemia. Typ IV is mostly linked

Additional Differential Diagnoses

  • Metabolic syndrome
  • Autosomal recessive inheritance
  • Autosomal dominant inheritance
  • Primary Genetic Disorders
  • Secondary Complications
  • Obesity and insulin resistance
  • diabetes mellitus

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_7725
oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
OMIM mapping confirmed by DO. [SN].
oboInOwl#hasAlternativeId
DOID:0050527
oboInOwl#id
DOID:1172
core#notation
DOID:1172
oboInOwl#hasDbXref
UMLS_CUI:C0020480
oboInOwl#hasExactSynonym
VLDL hyperlipoproteinemia
rdf-schema#label
hyperlipoproteinemia type IV
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_1168
relatedICD
http://example.org/icd10/E78.1
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.